baber/WOPTO huggingface dataset:
Patent NZ-581455-A (NZ)
Title: Method for cleaning surfaces of polyolefin-based materials soiled with food, particularly dairy products
Inventor: LAFFITTE JEAN-ALEX
IPC: C11D3/34
Filed: 2008-05-19
Abstract: Disclosed is a process for cleaning polyolefin-based equipment soiled with food, preferably wherein the equipment is soiled with dairy products, characterised by the use of aqueous cleaning compositions containing one or more short-chain alkanesulfonic acids containing from 1 to 4 carbon atoms, such as methanesulfonic acid (MSA).
Patent NZ-582880-A (NZ)
Title: Closure with rotatable protective cap with cut-out to selectively rotate relative to circumferentially spaced septum covered openings in an underlying closure
Inventor: GRUNERT LOTHAR
IPC: B65D51/00
Filed: 2008-06-02
Abstract: A closure (2) for closing an opening of a container (1) for storing and removing sterile or moisture-sensitive media has a closure cap (3), which can be connected to the container in a fluid-tight manner, and a piercable, self-closing septum, which closes at least one removal opening (7) in the closure cap (3) in a fluid-tight manner, wherein the closure (2) has a rotatably mounted protective cap (4) with a cutout (5). The cutout (5) is arranged off-centre in the protective cap (4) and the closure cap (3) has off-centre a closure region (9) which is not impinged by the at least one removal opening (7) and is larger than the cutout (5) in the protective cap (4). The closure (2) has a latching mechanism, which is suitable for arranging the protective cap (4) in relation to the closure cap (3) in such a way that the cutout (5) in the protective cap (4) is aligned either in line with the or a removal opening (7) in the closure cap (3) or at a distance from the removal opening or openings (7). The closure (2) has at least one tamper-proof means of protection.
Patent NZ-587292-A (NZ)
Title: Use of anti-CGRP (calcitonin gene-related peptide) antagonists to treat chronic pain
Inventor: CORRADINI LAURA
IPC: A61K39/395
Filed: 2009-03-03
Abstract: Provided is the use of an anti-CGRP antagonist antibody for the manufacture of a medicament for the prevention and/or treatment of chronic bone cancer pain and/or symptoms of chronic bone cancer pain. Specific antibodies with defined CDRs for this use are also disclosed.
Patent NZ-588496-A (NZ)
Title: Sealed and secure packaging methods
Inventor: RECKIN SHANE ROBERT
IPC: B65B7/02
Filed: 2010-10-11
Abstract: A method of sealing a product within a bag (1) is disclosed. The method includes firstly filling the bag (1) with a product, through an open end. Secondly, putting a product verification device (11), in the form of hot stamping hologram foil, which includes an optically variable device, in the region to be sealed (9). Finally, a heat sealer (14, 15) seals the hologram foil (11) to the bag (1), at the same time as it seals the bag (1).
Patent NZ-592057-A (NZ)
Title: Sulfur-linked compounds for treating opthalmic diseases and disorders
Inventor: SCOTT IAN L
IPC: C07C311/37
Filed: 2009-09-02
Abstract: Disclosed herein are sulphur linked aryl compounds of formula (Ib), (Ic) and (Ie), wherein the substituents are as defined within the specification; processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful treatment of an ophthalmic disease or disorder in a subject, particularly age-related macular degeneration or Stargardt's macular dystrophy, retinal detachment, hemorrhagic retinopathy, retinitis pigmentosa, optic neuropathy, inflammatory retinal disease, proliferative vitreoretinopathy, retinal dystrophy, hereditary optic neuropathy, Sorsby's fundus dystrophy, uveitis, a retinal injury, a retinal disorder associated with Alzheimer's disease, a retinal disorder associated with multiple sclerosis, a retinal disorder associated with Parkinson's disease, a retinal disorder associated with viral infection, a retinal disorder related to light overexposure, and a retinal disorder associated with AIDS.
Patent NZ-594342-A (NZ)
Title: Combinations of tralopyril and zinc sulphate (sulfate)
Inventor: KEMPEN TONY MATHILDE JOZEF
IPC: A01N43/36
Filed: 2007-01-31
Abstract: Disclosed is a composition comprising a combination of 4-bromo-2-(4-chlorophenyl)-5- (trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, as component (I), and ZnSO4 as component (II); whereby component (I) and one of the components (II) are in respective proportions to provide a synergistic effect against fouling organisms, wherein the ratio by weight of component (I) to one of the components (II) is 10:1 to 1:10. Also disclosed is a product containing (a) a composition comprising 4-bromo-2-(4-chloro-phenyl)-5-(trifluoromethyl)-1H-pyrrole-3-carbonitrile, or a salt thereof, as component (I), and (b) a composition comprising ZnSO4 as a component (II), wherein the compounds are administered simultaneously or sequentially, and wherein said (a) and (b) are in respective proportions which in use provide a synergistic effect against fouling organisms, wherein the ratio by weight of component (I) to one of the components (II) is 10:1 to 1:10.
Patent NZ-596070-A (NZ)
Title: Genetic variants contributing to risk of prostate cancer
Inventor: GUDMUNDSSON JULIUS
IPC: G16B20/40
Filed: 2010-05-07
Abstract: 596070 Discloses a method of determining a susceptibility to prostate cancer, the method comprising: Obtaining nucleic acid sequence data from a human individual, identifying at least one allele of at least one polymorphic marker, wherein the different alleles are associated with different susceptibilities to prostate cancer. Determining a susceptibility to prostate cancer from the nucleic acid sequence data, wherein the polymorphic marker is selected from the group consisting of rs16902094, and markers in linkage disequilibrium therewith.
Patent NZ-600059-A (NZ)
Title: Antibodies against cd38 for treatment of multiple myeloma
Inventor: PARREN PAUL
IPC: G01N33/50
Filed: 2006-03-23
Abstract: Disclosed is an antibody binding to human CD38 encoded by: (i) human light chain and human heavy chain nucleic acids comprising nucleotide sequences in their variable regions as set forth in SEQ ID No:21 and SEQ ID No:26, respectively; or (ii) human light chain and human heavy chain nucleic acids comprising nucleotide sequences in their variable regions, which are conservative sequence modifications of the sequences as set forth in (i). Further disclosed is an antibody binding to human CD38, comprising human light chain and human heavy variable regions, wherein the light chain variable region comprises a VL CDR1 having the sequence as set forth in SEQ ID No:23, a VL CDR2 having the sequence as set forth in SEQ ID No:24 and a VL CDR3 having the sequence as set forth in SEQ ID No:25, and the heavy chain variable region comprises a VH CDR1 having the sequence as set forth in SEQ ID No:28, a VH CDR2 having the sequence as set forth in SEQ ID No:29 and a VH CDR3 having the sequence as set forth in SEQ ID No:30.
Patent NZ-600405-A (NZ)
Title: Compositions and methods for treating colitis
Inventor: GARDNER JOSEPH H
IPC: A01N43/42
Filed: 2010-11-05
Abstract: Disclosed herein are compositions of methylpiperazine substituted 3-Hydroxy-2-Oxo-1,2-Dihydropyridine compounds and methods for treating colitis and other inflammatory bowel diseases, inter alia, indeterminate colitis, Crohn’s disease, irritable bowel syndrome and ischemic colitis. compounds of the disclosed compositions include: Methyl 4-{ [1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl]methyl} piperazine-1-carboxylate; Ethyl 4-{ [1-(4-fluorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl]methyl} piperazine-1-carboxylate; and tert-Butyl 4-{ [1-(2-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl]methyl} piperazine-1-carboxylate.
Patent NZ-602097-A (NZ)
Title: A cup with integral closure flaps
Inventor: LU WEI
IPC: B65D3/06
Filed: 2009-11-25
Abstract: A beverage cup having a lid formed by folding two sides of the rim inward is disclosed. The frusto-conical cup (1) is made from a flexible resilient material, having a circular rim (5) defining the top opening of the cup. A pair of arcuate crease lines (7, 8) is formed at the opposing sides of the wall (2) of the cup below the rim defining a pair of flaps (70, 80) for closing the top opening of the cup by folding the flaps along the crease lines. Due to the resilience of the cup material, each flap can toggle between two stable positions on application of an initial external force on the flap, namely an open upright position in which the flap is convex and forms part of the wall of the cup, and a closed slanted position in which the flap changes its shape to concave. In the closed mode, the rim of one flap impinges against the inner face of the second flap and forms a spill-tight seal between the flaps. The seal is maintained due to static opposing forces acting between the flaps.
Patent NZ-603133-A (NZ)
Title: An adjustable diverter or flow controller for a flow apparatus
Inventor: COOKE GRAEME
IPC: B03B5/32
Filed: 2011-04-28
Abstract: 603133 The present disclosure provides a diverter or flow controller 1.060 for controlling a flow on or within an apparatus 1.001 including at least one diverter or flow controller element 1.065 and one or more displacement members 1.064 adapted to move at least part of the diverter or flow controller element 1.065 or a corresponding one of the diverter or flow controller element 1.065 into or out of contact with a flow path. The disclosure also provides a remotely controlled diverter or flow controller and is applicable to flow devices or apparatus such as spiral concentrators and banks of these as up-current classifiers, hydraulic classifiers, teeter bed style classifiers, sluices, weirs, or channels.
Patent NZ-606684-A (NZ)
Title: Split permanent magnet machine
Inventor: KAMPER MAARTEN JAN
IPC: H02K19/36
Filed: 2011-08-04
Abstract: Disclosed is an electrical energy conversion system (11) including two permanent magnet machines (25, 27). A first of the two permanent magnet machines (25) has a stationary stator (21) which is connectable to an electrical system, and a second of the two permanent magnet machines (27) has a rotor (17) which is connectable to a mechanical system. The system (11) is characterised in that the two permanent magnet machines (25, 27) have a common freely rotating rotor (19) housing permanent magnets (39) and are magnetically separated from one another.
Patent NZ-606706-A (NZ)
Title: Device for dredging soil material under water
Inventor: HEILER JOHAN
IPC: E02F5/24
Filed: 2011-06-28
Abstract: Device for dumping material onto an underwater bottom or installation, such as a pipeline, comprises a vessel 1, provided with a fall pipe 2 through which the material is dumped on the underwater bottom, a steering device 5 adapted to control the motion of the fall pipe 2 relative to the underwater bottom, first monitoring means adapted to monitor the state of the underwater bottom, second monitoring means adapted to monitor the position of the steering device 5 relative to the bottom, and further monitoring means adapted to measure the flow rate of the material transmitted through the fall pipe 2 and the velocity of the vessel 1, and computing means adapted to compute, on the basis of data obtained from the first, the second and the further monitoring means, control signals for moving the steering device.
Patent NZ-610031-A (NZ)
Title: Use of nitrooxy organic molecules in feed for reducing methane emission in ruminants, and/or to improve ruminant performance
Inventor: DUVAL STEPHANE
IPC: A23K1/18
Filed: 2011-12-20
Abstract: The disclosure relates to the use of organic nitrooxy compounds of the formula (I) as an active compound in animal feeding for reducing the formation of methane emanating from the digestive activities of ruminants and/or improving ruminant performance. In formula (I), Y is CaHbOdNeSg, wherein a is between 1 and 25, b is between 2 and 51, d is between 0 and 8, e is between 0 and 5 and g is between 0 and 3. The ruminant may include: cattle, goats, sheep, giraffes, American Bison, European bison, yaks, water buffalo, deer, camels, alpacas, llamas, wildebeest, antelope, pronghorn, and nilgai. The disclosure also relates to a feed composition, and a method of reducing methane emission using these compounds. Specific examples of the nitrooxy compound include: 3-nitrooxypropanol, 5-nitrooxy-pentanenitrile, 5-nitrooxy-pentane, 3-nitrooxy-propyl propionate, 1,3-bis-nitrooxypropane, 1,4-bis-nitrooxybutane, 1,5-bis-nitrooxypentane, 3-nitrooxy-propyl benzoate, 3-nitrooxy-propyl hexanoate, 3-nitrooxy-propyl 5-nitrooxy-hexanoate, isosorbid-dinitrate, and N-[2-(nitrooxy)ethyl]-3-pyridinecarboxamide, and bis-(2-nitrooxyethyl) ether.
Patent NZ-619258-A (NZ)
Title: Phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanones and the use thereof as medicament
Inventor: GIOVANNINI RICCARDO
IPC: C07D471/04
Filed: 2012-08-02
Abstract: Provided are phenyl-3-aza-bicyclo[3.1.0]hex-3-yl-methanone derivative compounds of general formula (I), wherein the variables are as described in the specification. Examples of the compounds include [5-Methanesulfonyl-2-(2,2,2-trifluoro-1-methyl-ethoxy)-phenyl]-[1-(5-trifluoromethyl-[1,2,4]oxadiazol-3-yl)-3-aza-bicyclo[3.1.0]hex-3-yl]-methanone and [5-Methanesulfonyl-2-(2,2,2-trifluoro-1-methyl-ethoxy) phenyl]-{ 1-[5-(3-methyl-oxetan-3-yl)-[1,2,4]oxadiazol-3-yl]-3-aza-bicyclo[3.1.0]hex-3-yl} -methanone. The compounds are glycine transporter-1 (GlyT1) inhibitors. The compounds may be useful in the treatment of the positive and negative symptoms of schizophrenia as well as cognitive impairments associated with schizophrenia, Alzheimer’s disease and other neurological and psychiatric disorders.
Patent NZ-622100-A (NZ)
Title: Integrated private branch exchange and device control system
Inventor: ORELLANA ALEJANDRO
IPC: H04L29/00
Filed: 2012-09-04
Abstract: Disclosed is an apparatus including a memory configured to store software (245) for execution by the processor. The software (245) includes a state center (235) that when executed is operable to process a registration message from an endpoint that supports voice over Internet Protocol (VoIP) calling. The registration message indicates a telephony event involving the endpoint and an Internet Protocol private branch exchange (IP PBX) (340) separate from the apparatus. The telephony event is the endpoint registering with the IP PBX (340), the endpoint placing a call through the IP PBX (340), or the endpoint receiving a call via the IP PBX (340). Based on the registration message, a control state is updated to indicate the telephony event involving the endpoint, and a notification message is sent to one or more first devices that have registered to receive notification messages from the state center (235) for telephony events, to inform the one or more first devices of occurrence of the telephony event involving the endpoint and to cause at least one first device to perform a responsive action that controls an audio/video (A/V) or home automation device in response to the telephony event. A method of using such an apparatus is also disclosed.
Patent NZ-624068-A (NZ)
Title: Fused tricyclic compounds as raf kinase inhibitors
Inventor: WANG SHAOHUI
IPC: C07D519/00
Filed: 2011-12-31
Abstract: Provided are fused tricyclic compounds of the general formula I, wherein the variables are as defined in the specification. Examples of the compounds include (±)-exo-5-((1(1H-benzo[d]imidazol-2-yl)-1,1a,6,6a-tetrahydrocyclopropa[a]inden-3-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one and (±)-exo-5-((1-(5-fluoro-6-methyl-1H-benzo[d]imidazol-2-yl)-1a,6b-dihydro-1H-cylopropa[b]benzofuran-5-yl)oxy)-3,4-dihydro-1,8-naphthyridin-2(1H)-one. The compounds are inhibitors of RAF kinase. The compounds may be useful in the treatment of cancer.
Patent NZ-705325-A (NZ)
Title: Cable dispenser
Inventor: Nicholas john brown
IPC: B65H49/28
Filed: 2015-02-23
Abstract: The cable dispenser of the present invention includes a rotating platform having a support surface onto which a cable spool may be placed. The outer edge of the platform includes a face orientated at 90° to the support surface of the platform. The cable dispenser also includes a base configured to be placed on a surface such that the rotating platform is aligned substantially horizontally. An outer edge of the base is inclined which may allow cable spilling off the spool (due to over spinning for example) to move up the side of the base towards and against or onto the outer surface of the platform which is configured to act as a relatively large diameter rotating axle. The platform further includes a first support surface and a second support surface wherein the first support surface includes a flat surface recessed into the platform, an outer edge of the first support surface being a circle concentric with a circular outer perimeter of the platform.
Patent NZ-715526-A (NZ)
Title: System and method for role negotiation in multi-reality environments
Inventor: DILLAVOU MARCUS
IPC: G06F17/00
Filed: 2014-06-27
Abstract: Provided herein are methods and systems for role negotiation with multiple sources. A method for role negotiation can comprise rendering a common field of interest that reflects a presence of a plurality of elements, wherein at least one of the elements is a remote element located remotely from another of the elements. A plurality of role designations can be received, each role designation associated with one of a plurality of devices, wherein at least one of the plurality of devices is a remote device located remotely from another of the plurality of devices. The common field of interest can be updated based upon the plurality of role designations, wherein each of the plurality of role designations defines an interactive functionality associated with the respective device of the plurality of devices. The ingress and/or egress of information to the one or more of the plurality of devices is managed based upon one or more of the plurality of role designations, wherein each of the plurality of role designations defines a transmission rule for managing ingress and egress of information associated with the respective device of the plurality of devices, wherein the transmission rule comprises one or more of a latency parameter and a bandwidth parameter, and wherein the transmission rule defines a portion of image processing to be offloaded to a proxy server.
Patent NZ-720743-A (NZ)
Title: Peptidomimetic compounds and antibody-drug conjugates thereof
Inventor: FLYGARE JOHN
IPC: A61P35/00
Filed: 2014-12-16
Abstract: This invention relates to peptidomimetic linkers, cleavable by lysosomal enzymes and anti-body drug conjugates thereof, pharmaceutical compositions containing them, and to their use in therapy for the prevention and treatment of cancer. The drug of the anti-body drug conjugate being a Pyrrolobenzodiazepine dimer.
Patent NZ-725905-A (NZ)
Title: Tal-effector nuclease for targeted knockout of the hiv co-receptor ccr5
Inventor: MOCK ULRIKE
IPC: C12N15/90
Filed: 2015-05-04
Abstract: The invention relates to a novel TAL effector nuclease (TALEN) for targeted knockout of the HIV co-receptor CCR5. One aspect of the invention therefore provides a TAL effector nuclease pair comprising a first and a second TAL effector nuclease monomer, wherein each TAL effector nuclease monomer comprises an endonuclease domain having type II endonuclease activity and a TAL effector DNA binding domain having a plurality of repeat units, each comprising a variable amino acid pair RVD, and wherein a) the TAL effector DNA binding domain of the first TAL effector nuclease monomer binds to the target sequence GCTGGTCATCCTCATCCTG (SEQ ID NO: 1) and/or comprises the RVD sequence NH HD NG NH NH NG HD NI NG HD HD NG HD NI NG HD HD NG NN, and b) the TAL effector DNA binding domain of the second TAL effector nuclease monomer binds to the target sequence AGATGTCAGTCATGCTCTT (SEQ ID NO: 2) and/or comprises the RVD sequence NI NN NI NG NN NG HD NI NH NG HD NI NG NH HD NG HD NG NG.
Patent NZ-727616-A (NZ)
Title: Novel adjuvant compositions
Inventor: BAGI CEDO MARTIN
IPC: A61K39/39
Filed: 2009-06-24
Abstract: An adjuvant formulation comprising a triterpenoid saponin, a sterol, a quaternary ammonium compound, and a polyacrylic acid polymer. The saponin is Quil A or a purified fraction thereof, the sterol is cholesterol, and the quaternary ammonium compound is dimethyl dioctadecyl ammonium bromide (DDA). A vaccine comprises the above described adjuvant formulation and antigenic component. The antigenic component comprises Feline Leukemia Virus and the antigen component further comprises at least one of Feline Immunodeficiency Virus, Feline Viral Rhinotracheitis virus, Feline Calicivirus, Feline Enteric Coronavirus, Feline Infectious Peritonitis Virus, and Chlamydia pisttaci.
Patent NZ-731128-A (NZ)
Title: Absorbent article
Inventor: TASHIRO IZUMI
IPC: A61F13/53
Filed: 2015-09-25
Abstract: The present invention is to provide an absorbent article allowing a soft feel to be given to a user even near intersection points intersected by the diagonally extending components. The absorbent article (10) according to the present invention having a liquid-permeable top sheet (14), a liquid-impermeable back sheet (12), and an absorber (13) disposed between the top sheet and the back sheet includes a first recessed portion (20a) configured in a top surface of the absorber facing the top sheet and extending along a first direction and a second recessed portion (20b) configured in the top surface of the absorber facing the top sheet so as to intersect the first recessed portion, the second recessed portion extending along a second direction different from the first direction. The first recessed portion and the second recessed portion each have a first area (201) having a shallow depth from the surface of the top sheet to a bottom surface of the first area and a second area (202) having a deeper depth from the top surface of the absorber to a bottom surface of the second area than the first area. Q1/Q4 is in a range of 0.425 to 0.975, where Q1 is a depth from the surface of the top sheet in an undeformed area to the bottom surface in the second area, and Q4 is the thickness of the top sheet and the absorber in the undeformed area.
Patent NZ-738072-A (NZ)
Title: Curable film-forming compositions containing photothermally active materials, coated metal substrates, and methods of coating substrates
Inventor: WALTERS DAVID
IPC: C09D171/00
Filed: 2016-05-11
Abstract: A curable film-forming composition is provided, comprising: (a) a curing agent comprising reactive functional groups; (b) a compound comprising functional groups reactive with the reactive functional groups in (a); and (c) a photothermally active material. The composition may further include a catalyst component. Coated substrates are also provided using the compositions described, as well as methods for coating a substrate using the compositions.
Patent NZ-738675-A (NZ)
Title: Methods and compositions for treating aging-associated conditions
Inventor: WYSS-CORAY ANTON
IPC: A61K38/16
Filed: 2016-06-06
Abstract: Methods of treating an adult mammal for an aging-associated condition are provided. Aspects of the methods include enhancing a TIMP activity, e.g., a TIMP2 activity, in the mammal in a manner sufficient to treat the adult mammal for the aging-associated condition. Also provided are compositions for use in practicing methods of the invention. A variety of aging-associated conditions may be treated by practice of the methods, which conditions include cognitive impairments.
Patent NZ-739338-A (NZ)
Title: Rapid-acting insulin compositions
Inventor: CHRISTE MICHAEL EDWARD
IPC: A61K47/12
Filed: 2016-08-19
Abstract: The invention is a pharmaceutical composition of human insulin or insulin analog that includes citrate, treprostinil and stabilizing agents, that has faster pharmacokinetic and/or pharmacodynamic action than commercial formulations of existing insulin analog products and that is stable for commercial use.